Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.42 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.41 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.41 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.41 |
| ▸ | NPY2R | P49146 | 7/20 | 0.40 |
| ▸ | NPY4R | P50391 | 7/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.40 |
| ▸ | NPY1R | P25929 | 5/20 | 0.40 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.40 |
| ▸ | CALCR | P30988 | 3/20 | 0.40 |
| ▸ | AKT1 | P31749 | 2/20 | 0.40 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30523349 | 0.97 | EPHA2 (0.42) | EPHA2CXCR4NMUR2NMUR1NPY2R | |
| SCHEMBL29565794 | 0.88 | GRB2 (0.44) | EPHA2CXCR4NMUR2NMUR1RAMP3 | |
| SCHEMBL8937029 | 0.87 | EPHA2 (0.45) | EPHA2CXCR4NMUR2NMUR1NPY2R | |
| SCHEMBL8937041 | 0.87 | EPHA2 (0.45) | EPHA2CXCR4NMUR2NMUR1NPY2R | |
| SCHEMBL30437074 | 0.84 | EPHA2 (0.41) | EPHA2 | |
| SCHEMBL30671935 | 0.84 | GRB2 (0.44) | NPY1R | |
| SCHEMBL23229944 | 0.83 | ACE (0.41) | — | |
| SCHEMBL1404295 | 0.83 | ACE (0.41) | — | |
| SCHEMBL1404290 | 0.83 | ACE (0.41) | — | |
| SCHEMBL664013 | 0.83 | ELANE (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4421088-A2 | C-PEPTIDE'S INTERACTION WITH ELASTIN RECEPTOR, A BLUEPRINT FOR UNDERSTANDING VASCULAR DISEASE | Uit de Krempe IP B.V. (NL) | 2024-08-28 | — | — | EP | disclosed |
| EP-3577462-B1 | INTERACTION BETWEEN C-PEPTIDES AND ELASTIN RECEPTOR, A MODEL FOR UNDERSTANDING VASCULAR DISEASE | RESILIUN B V (NL) | 2024-04-17 | — | — | EP | disclosed |
| US-20230173089-A1 | Q-ER PEPTIDE | BIOTEMPT B.V. (NL) | 2023-06-08 | — | — | US | disclosed |